Echo Street Capital Management LLC Repligen Corp Transaction History

Echo Street Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$138.42 - $180.31 $80.2 Million - $104 Million	-579,519 Reduced 99.49%	2,958 $418,000
Q1 2023 May 12, 2023	BUY	$154.26 - $198.1 $36.6 Million - $47 Million	237,084 Added 68.64%	582,477 $98.1 Million
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $24.4 Million - $33.2 Million	-150,405 Reduced 30.34%	345,393 $58.5 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $29.9 Million - $47.7 Million	-186,156 Reduced 27.3%	495,798 $92.8 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $16.8 Million - $22.5 Million	119,705 Added 21.29%	681,954 $111 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $17.4 Million - $27.8 Million	107,884 Added 23.74%	562,249 $106 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $8.5 Million - $10.5 Million	-34,334 Reduced 7.03%	454,365 $120 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $94.9 Million - $158 Million	487,354 Added 36234.5%	488,699 $141 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $351,644 - $468,414	-2,120 Reduced 61.18%	1,345 $268,000
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $624,982 - $783,990	3,465 New	3,465 $674,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.